Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.

Area of Science:

• Molecular biology
• Cancer genetics
• Proteomics

Background:

• BRCA1 protein is crucial for DNA repair and cell cycle control.
• Missense mutations in BRCA1 increase breast and ovarian cancer risk.
• Mechanisms of BRCA1-related tumorigenesis and proteomic changes are poorly understood.

Purpose of the Study:

• To investigate proteomic alterations in cells with specific BRCA1 missense mutations.
• To identify molecular events triggered by BRCA1 mutations linked to breast cancer susceptibility.
• To evaluate the potential of specific proteins as biomarkers for BRCA1-associated cancers.

Main Methods:

• Stable transfection of HeLa cells with wild-type and mutant BRCA1 cDNA (Ser1841Asn, Met1775Arg, Trp1837Arg).
• Whole-cell proteome analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
• Focus on differential protein expression, particularly tumor protein D52 (TD52) and folate receptor alpha (FOL1).

Main Results:

• BRCA1 Met1775Arg and Trp1837Arg mutations did not significantly alter the proteomic profile.
• The BRCA1 Ser1841Asn mutation induced distinct proteomic changes compared to wild-type.
• Expression of TD52 and FOL1 was notably affected in cells with the Ser1841Asn mutation.

Conclusions:

• The BRCA1 Ser1841Asn mutation activates specific protein pathways distinct from other mutations.
• TD52 and FOL1 show potential as biomarkers for breast cancer in patients with the Ser1841Asn BRCA1 alteration.
• Further research is needed to elucidate the precise role of these proteins in BRCA1-related tumorigenesis.